Data / Form D filings / iQure Pharma Inc.
iQure Pharma Inc.: Form D filings
iQure Pharma Inc., a company in Skillman, NJ, filed 6 Form D notices with the SEC between 2023 and 2026. The latest, on September 21, 2026, reports $2.8 million sold of a $4 million offering to 18 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 KITTANSETT COURT, Skillman, NJ, 08558
- Phone
- (312) 741-1606
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1996977
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Amendment | $4,000,000 | $2,788,315 | $1,211,685 | 18 | Sep 9, 2025 | sec.gov |
| Jun 3, 2026 | New notice | $4,000,000 | $650,000 | $3,350,000 | 1 | May 27, 2026 | sec.gov |
| Nov 3, 2025 | New notice | $1,750,000 | $1,503,320 | $246,680 | 14 | Sep 9, 2025 | sec.gov |
| Jan 16, 2025 | New notice | $1,443,786 | $1,443,786 | 2 | Dec 20, 2024 | sec.gov | |
| Apr 16, 2024 | New notice | Indefinite | $220,000 | 7 | Apr 5, 2024 | sec.gov | |
| Oct 11, 2023 | New notice | $2,000,000 | $1,500,000 | $500,000 | 13 | Oct 4, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Pawel Zolnierczyk | Executive Officer |
Other companies in New Jersey that filed recently
- CORE X Partners LLC $162,249 · Nov 2, 2026
- CORE X SRS Regional LLC $10.6 million · Oct 20, 2026
- Less Noise More Signal Inc. $1.7 million · Oct 14, 2026
- ELK Holdco, LLC $49.9 million · Oct 13, 2026
- OceanTailer, Inc. $75,000 · Oct 7, 2026
- YM Corp offering · Sep 28, 2026
Every Form D from the week of Sep 21, 2026 · All recent filings in New Jersey · All recent Other filings
Read from SEC EDGAR. Amount sold is what iQure Pharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.